Search

Search Results
Results 341 - 350 of 706 for Depression
  • Iptam Migraine Relief
    Drug - 9 Mar 2023
    Consumer Medicine Information (CMI) about Iptam Migraine Relief intended for persons living in Australia.
  • Brevinor
    Drug - 6 Mar 2023
    Consumer Medicine Information (CMI) about Brevinor (Ethinylestradiol and Norethisterone) intended for persons living in Australia.
  • Brevinor-1
    Drug - 6 Mar 2023
    Consumer Medicine Information (CMI) about Brevinor-1 (Ethinylestradiol and Norethisterone) intended for persons living in Australia.
  • Demazin Original 6-hour Relief
    Drug - 27 Feb 2023
    Consumer Medicine Information (CMI) about Demazin Original 6-hour Relief intended for persons living in Australia.
  • Rydapt
    Drug - 20 Feb 2023
    Consumer Medicine Information (CMI) about Rydapt intended for persons living in Australia.
  • Xalamol 50/5
    Drug - 17 Jan 2023
    Consumer Medicine Information (CMI) about Xalamol 50/5 (latanoprost and timolol) intended for persons living in Australia.
  • Imatinib-Teva
    Drug - 9 Jan 2023
    Consumer Medicine Information (CMI) about Imatinib-Teva intended for persons living in Australia.
  • Perisyl Combi
    Drug - 6 Jan 2023
    Consumer Medicine Information (CMI) about Perisyl Combi (perindopril erbumine and indapamide hemihydrate) intended for persons living in Australia.
  • Salpraz Heartburn Relief (reformulation 2)
    Drug - 5 Jan 2023
    Consumer Medicine Information (CMI) about Salpraz Heartburn Relief (reformulation 2) (Pantoprazole enteric coated tablets) intended for persons living in Australia.
  • Retrovir
    Drug - 2 Dec 2022
    Consumer Medicine Information (CMI) about Retrovir intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback